球狀體市場 - 全球產業規模、佔有率、趨勢、機會和預測，按類型、按方法、按來源、按應用、按地區和競爭進行細分，2020-2030 年

2024 年全球球體市場價值為 7.5284 億美元，預計到 2030 年將達到 24.8301 億美元，複合年成長率為 21.98%。由於全球球體市場在臨床前和轉化研究中的重要性日益增加，其發展勢頭強勁。由於 3D 細胞培養系統比傳統的 2D 培養具有更高的生理準確性，研究人員正轉向使用球體進行癌症生物學、幹細胞研究和再生醫學等應用。這些球形細胞簇可以更有效地模擬體內環境，從而為藥物篩選和毒性研究提供更具預測性的模型。製藥公司正在大力投資以球體為基礎的平台，以降低早期藥物開發的成本和失敗率。生物列印、微流體和無支架培養技術的持續創新進一步增強了球體系統的功能性和可擴展性，使其更容易被更廣泛的實驗室和 CRO 使用。

影響市場的一個主要趨勢是支援高通量篩選的自動化細胞球生成平台的快速商業化，從而幫助藥物開發商縮短研發週期。人工智慧和機器學習與細胞球成像和分析的結合，使研究人員能夠更精確地獲得更深入的生物學見解。生技公司與學術機構之間的合作日益密切，促進了知識交流和更快的創新週期。各公司也推出了新型微孔板，例如超低附著板，以支持細胞球的穩定和可重複生長。此外，人們對類器官和患者來源的腫瘤模型的興趣日益濃厚，也增加了對先進3D細胞培養基礎設施的需求。這些發展正在推動細胞球在基礎研究和應用生物醫學領域從實驗應用向主流應用的轉變。

儘管成長強勁，但市場仍面臨諸多挑戰，這些挑戰可能會影響其擴張速度。先進的細胞球平台和耗材成本高昂，限制了小型研究機構和新創企業的可及性。標準化仍然是一個問題，因為不同實驗室的細胞球形成、培養和資料解讀方案通常差異很大。關於將基於細胞球的模型研究結果轉化為臨床應用的監管不確定性，阻礙了其在藥物核准流程中更廣泛的應用。技術限制，例如如何實現細胞球的均勻大小和維持細胞球的長期活力，也仍然存在。在發展中地區，認知度有限和缺乏熟練的人員進一步阻礙了細胞球的普及。透過成本最佳化、技術培訓和跨行業合作來應對這些挑戰，對於維持長期市場成長至關重要。

關鍵市場促進因素

對先進3D細胞培養模型的需求不斷成長

主要市場挑戰

球體形成和分析缺乏標準化

主要市場趨勢

轉向高通量3D篩選平台

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球球體市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依類型（多細胞腫瘤球體 (MCTS)、神經球、乳球、肝球、胚狀體）
  • 按方法（微圖案化板、低細胞附著板、懸滴法、其他）
  • 依來源（細胞株、​​原代細胞、iPSC 衍生細胞）
  • 按應用（發育生物學、個人化醫療、再生醫學、疾病病理學研究、藥物毒性和功效測試）
  • 按公司分類（2024）
  • 按地區
• 市場地圖

第6章：北美球體市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 墨西哥
  • 加拿大

第7章：歐洲球體市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 法國
  • 德國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太球體市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 韓國
  • 日本
  • 澳洲

第9章：南美洲球狀體市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東和非洲球體市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 合併與收購（如有）
• 產品發布（如有）
• 最新動態

第13章：干擾：衝突、流行病與貿易壁壘

第 14 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 15 章：競爭格局

• Thermo Fisher Scientific Inc.
• Corning Incorporated
• Merck KGaA
• Lonza Group AG
• InSphero AG
• Greiner Bio-One International GmbH
• 3D Biotek LLC
• CN Bio Innovations
• Kuraray Co., Ltd.
• Tecan Group Ltd.

第 16 章：策略建議

第17章調查會社について,免責事項

Global Spheroids Market was valued at USD 752.84 Million in 2024 and is expected to reach USD 2483.01 Million by 2030 with a CAGR of 21.98%. The Global Spheroids Market is experiencing significant momentum due to its increasing relevance across preclinical and translational research. As 3D cell culture systems offer improved physiological accuracy compared to traditional 2D cultures, researchers are shifting toward spheroids for applications such as cancer biology, stem cell research, and regenerative medicine. These spherical cell clusters mimic in vivo environments more effectively, enabling more predictive modeling for drug screening and toxicity studies. Pharmaceutical companies are investing heavily in spheroid-based platforms to reduce the cost and failure rates associated with early-stage drug development. Continuous innovation in bioprinting, microfluidics, and scaffold-free culture techniques is further enhancing the functionality and scalability of spheroid systems, making them more accessible to a broader spectrum of laboratories and CROs.

A major trend shaping the market is the rapid commercialization of automated spheroid generation platforms that support high-throughput screening, helping drug developers accelerate R&D cycles. The integration of artificial intelligence and machine learning into spheroid imaging and analysis is allowing researchers to derive deeper biological insights with greater precision. Collaborations between biotech firms and academic institutions are intensifying, fostering knowledge exchange and faster innovation cycles. Companies are also launching novel microplate formats, such as ultra-low attachment plates, to support consistent and reproducible spheroid growth. Moreover, growing interest in organoids and patient-derived tumor models is increasing the demand for advanced 3D cell culture infrastructure. These developments are fostering the transition from experimental to mainstream use of spheroids in both basic research and applied biomedical sciences.

Despite strong growth, the market faces several challenges that could impact its pace of expansion. High costs of advanced spheroid platforms and consumables limit accessibility for smaller research facilities and startups. Standardization remains an issue, as protocols for spheroid formation, culture, and data interpretation often vary widely between laboratories. Regulatory uncertainties regarding the clinical translation of findings from spheroid-based models hinder wider acceptance in drug approval pipelines. Technical limitations, such as achieving uniform size and maintaining long-term viability of spheroids, also persist. In developing regions, limited awareness and lack of skilled personnel further slow adoption. Addressing these challenges through cost optimization, technical training, and cross-industry collaborations will be critical for sustaining long-term market growth.

Key Market Drivers

Rising Demand for Advanced 3D Cell Culture Models

The rising demand for advanced 3D cell culture models is significantly propelling the growth of the Global Spheroids Market. Traditional 2D culture systems often fall short in replicating human tissue complexity, frequently leading to poor predictive outcomes in drug development. Spheroids, with their three-dimensional architecture, mimic in vivo cellular environments more effectively offering benefits such as realistic oxygen gradients, enhanced cell-cell and cell-matrix interactions, and metabolite diffusion patterns. These characteristics improve translational fidelity in preclinical testing, helping to reduce costly late-stage failures in drug pipelines.

This shift toward more physiologically accurate models is backed by substantial government support. The U.S. National Institutes of Health (NIH) allocated approximately USD 27 million in 2020, increasing to about USD 28.5 million in 2021, toward its Human Biomolecular Atlas Program (HuBMAP), which focuses on single-cell resolution mapping of human tissues, underscoring growing institutional commitment to high-fidelity tissue modeling. As a broader initiative, NIH's emphasis on funding development of 3D human tissue models reinforces the momentum behind model systems like spheroids.

In oncology and toxicology, spheroids are increasingly used for high-content screening, drug resistance studies, and cytotoxicity assays. Innovations in automation, microfabrication, and imaging tools are smoothing integration of these models into laboratory workflows. Regulatory bodies and funding agencies are encouraging adoption of 3D systems in line with ethical imperatives to reduce animal testing, while also enhancing experimental accuracy. This convergence of scientific need, technological readiness, and institutional endorsement positions spheroids as a vital component of modern biomedical research infrastructure, driving sustained demand across therapeutic areas and research domains.

Key Market Challenges

Lack of Standardization in Spheroid Formation and Analysis

One of the most pressing challenges faced by the Global Spheroids Market is the lack of standardization in spheroid formation and analysis. Spheroids are three-dimensional aggregates of cells used in a range of biomedical applications, but the absence of uniform protocols leads to inconsistent results, limiting their reliability and comparability across laboratories and studies. The formation of spheroids depends heavily on variables such as cell type, culture medium composition, aggregation technique, and incubation conditions. Without standardized methods, even minor deviations in these parameters can result in significant variation in spheroid size, morphology, and cellular behavior. This inconsistency becomes a barrier for researchers trying to reproduce or validate findings across different institutions, which is crucial in preclinical drug testing and disease modeling.

Another critical issue lies in the analysis of spheroids. Imaging and quantification of spheroid characteristics such as size, viability, and structural integrity often require sophisticated tools and expertise. Yet, no universally accepted protocols or metrics exist for evaluating these parameters. This variation can impact the interpretation of drug efficacy and toxicity, thereby slowing regulatory acceptance and industrial adoption. The challenge is further compounded when spheroids are integrated with co-culture systems or used in dynamic platforms such as organ-on-a-chip devices. These complex models make data interpretation even more difficult without consistent analytical guidelines.

The lack of standardization also affects scalability for commercial and clinical applications. Biotech firms developing 3D models for high-throughput screening or personalized medicine face difficulties in ensuring batch-to-batch consistency. This undermines investor confidence and hampers broader market penetration. Without established standards, regulatory bodies may also hesitate to accept spheroid-based models in place of conventional methods. The development of consensus-driven protocols, possibly through industry-academic collaborations or regulatory frameworks, will be essential to address these challenges and unlock the full potential of spheroid-based technologies.

Key Market Trends

Shift Towards High-Throughput 3D Screening Platforms

A significant trend shaping the Global Spheroids Market is the increasing shift towards high-throughput 3D screening platforms, driven by the need for more predictive, efficient, and physiologically relevant models in drug discovery and toxicology. Traditional 2D cell culture models have long been the standard in pharmaceutical research, but they often fall short in accurately replicating human tissue complexity. This has led to a growing preference for 3D spheroid-based models, which offer better cell-to-cell and cell-to-matrix interactions, making them highly suitable for simulating in vivo conditions. As the pharmaceutical industry pushes for faster and more accurate preclinical screening, high-throughput systems that can generate and analyze hundreds or thousands of spheroids simultaneously are becoming increasingly vital.

Technological advancements in microplate design, liquid handling automation, and imaging systems have enabled the development of platforms that support automated spheroid formation, culture maintenance, and real-time data collection. These innovations are allowing researchers to test multiple drug candidates across different spheroid models with greater speed and reliability. Companies are also integrating artificial intelligence and machine learning tools to streamline data analysis, enhancing decision-making in early-stage drug development. The scalability and reproducibility offered by high-throughput 3D platforms are attracting widespread interest from pharmaceutical and biotech firms aiming to reduce time-to-market for new therapies. This trend is expected to accelerate the adoption of spheroids in screening applications and drive sustained market growth.

Key Market Players

• Thermo Fisher Scientific Inc.
• Corning Incorporated
• Merck KGaA
• Lonza Group AG
• InSphero AG
• Greiner Bio-One International GmbH
• 3D Biotek LLC
• CN Bio Innovations
• Kuraray Co., Ltd.
• Tecan Group Ltd.

Report Scope:

In this report, the Global Spheroids Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Spheroids Market, By Type:

• Multicellular Tumor Spheroids (MCTS)
• Neurospheres
• Mammospheres
• Hepatospheres
• Embryoid Bodies

Spheroids Market, By Method:

• Micropatterned Plates
• Low Cell Attachment Plates
• Hanging Drop Method
• Others

Spheroids Market, By Source:

• Cell Line
• Primary Cell
• iPSCs Derived Cells

Spheroids Market, By Application:

• Developmental Biology
• Personalized Medicine
• Regenerative Medicine
• Disease Pathology Studies
• Drug Toxicity & Efficacy Testing

Spheroids Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Spheroids Market.

Available Customizations:

Global Spheroids Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Spheroids Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Multicellular Tumor Spheroids (MCTS), Neurospheres, Mammospheres, Hepatospheres, Embryoid Bodies)
  • 5.2.2. By Method (Micropatterned Plates, Low Cell Attachment Plates, Hanging Drop Method, Others)
  • 5.2.3. By Source (Cell Line, Primary Cell, iPSCs Derived Cells)
  • 5.2.4. By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Spheroids Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Method
  • 6.2.3. By Source
  • 6.2.4. By Application
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Spheroids Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Method
      • 6.3.1.2.3. By Source
      • 6.3.1.2.4. By Application
  • 6.3.2. Mexico Spheroids Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Method
      • 6.3.2.2.3. By Source
      • 6.3.2.2.4. By Application
  • 6.3.3. Canada Spheroids Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Method
      • 6.3.3.2.3. By Source
      • 6.3.3.2.4. By Application

7. Europe Spheroids Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Method
  • 7.2.3. By Source
  • 7.2.4. By Application
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Spheroids Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Method
      • 7.3.1.2.3. By Source
      • 7.3.1.2.4. By Application
  • 7.3.2. Germany Spheroids Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Method
      • 7.3.2.2.3. By Source
      • 7.3.2.2.4. By Application
  • 7.3.3. United Kingdom Spheroids Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Method
      • 7.3.3.2.3. By Source
      • 7.3.3.2.4. By Application
  • 7.3.4. Italy Spheroids Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Method
      • 7.3.4.2.3. By Source
      • 7.3.4.2.4. By Application
  • 7.3.5. Spain Spheroids Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Method
      • 7.3.5.2.3. By Source
      • 7.3.5.2.4. By Application

8. Asia-Pacific Spheroids Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Method
  • 8.2.3. By Source
  • 8.2.4. By Application
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Spheroids Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Method
      • 8.3.1.2.3. By Source
      • 8.3.1.2.4. By Application
  • 8.3.2. India Spheroids Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Method
      • 8.3.2.2.3. By Source
      • 8.3.2.2.4. By Application
  • 8.3.3. South Korea Spheroids Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Method
      • 8.3.3.2.3. By Source
      • 8.3.3.2.4. By Application
  • 8.3.4. Japan Spheroids Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Method
      • 8.3.4.2.3. By Source
      • 8.3.4.2.4. By Application
  • 8.3.5. Australia Spheroids Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Method
      • 8.3.5.2.3. By Source
      • 8.3.5.2.4. By Application

9. South America Spheroids Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Method
  • 9.2.3. By Source
  • 9.2.4. By Application
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Spheroids Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Method
      • 9.3.1.2.3. By Source
      • 9.3.1.2.4. By Application
  • 9.3.2. Argentina Spheroids Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Method
      • 9.3.2.2.3. By Source
      • 9.3.2.2.4. By Application
  • 9.3.3. Colombia Spheroids Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Method
      • 9.3.3.2.3. By Source
      • 9.3.3.2.4. By Application

10. Middle East and Africa Spheroids Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Method
  • 10.2.3. By Source
  • 10.2.4. By Application
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Spheroids Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Method
      • 10.3.1.2.3. By Source
      • 10.3.1.2.4. By Application
  • 10.3.2. Saudi Arabia Spheroids Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Method
      • 10.3.2.2.3. By Source
      • 10.3.2.2.4. By Application
  • 10.3.3. UAE Spheroids Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Method
      • 10.3.3.2.3. By Source
      • 10.3.3.2.4. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Disruptions: Conflicts, Pandemics and Trade Barriers

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Corning Incorporated
• 15.3. Merck KGaA
• 15.4. Lonza Group AG
• 15.5. InSphero AG
• 15.6. Greiner Bio-One International GmbH
• 15.7. 3D Biotek LLC
• 15.8. CN Bio Innovations
• 15.9. Kuraray Co., Ltd.
• 15.10. Tecan Group Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer